CD19 and cancer: Cancer cells adapt to either evade standard immune checks and balances or directly influence an immune phenotype conducive toward malignant proliferation, such as via recruitment and differentiation of Tregs, B regs, CD5þ B, and CD19+ B cells within the tumor microenvironment.